Our finding further supports the key role of EPHX2 expression and activity in decreasing EET levels; thus, their anti-inflammatory benefits in mature adipocytes as well as in obesity and its related metaflammation. Here, EPHX2 is linked to obesity due to melanocortin 4 receptor deficiency.